Keyword Analysis & Research: pegylated filgrastim


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
pegylated filgrastim1.520.79868920
pegylated1.130.31137609
filgrastim1.110.172642210

Keyword Research: People who searched pegylated filgrastim also searched

Keyword CPC PCC Volume Score
pegylated filgrastim0.510.5261039

Search Results related to pegylated filgrastim on Search Engine

  • Pegfilgrastim - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Pegfilgrastim

    WebPegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils). Pegfilgrastim was developed by Amgen.

    DA: 74 PA: 89 MOZ Rank: 34

  • Pegfilgrastim - StatPearls - NCBI Bookshelf

    nih.gov

    https://www.ncbi.nlm.nih.gov/books/NBK532893/

    WebFeb 5, 2024 · Pegfilgrastim is a pegylated granulocyte colony-stimulating factor that is FDA-approved to decrease the risk of patients developing febrile neutropenia when receiving myelosuppressive chemotherapy regimens.

    DA: 1 PA: 24 MOZ Rank: 97

  • Pegfilgrastim: Uses, Dosage, Side Effects, Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/pegfilgrastim.html

    WebJan 8, 2024 · Pegfilgrastim is a pegylated or long-acting form of recombinant G-CSF, which means that it stays in your body for longer and doesn't need to be administered as often. Pegfilgramstim is a type of biological drug. The original version of pegfilgrastim is called Neulasta and it was approved by the US Food and Drug Administration (FDA) in …

    DA: 44 PA: 33 MOZ Rank: 92

  • Pegfilgrastim: Uses, Interactions, Mechanism of Action

    drugbank.com

    https://go.drugbank.com/drugs/DB00019

    WebPegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. 2 The drug is approved for use to decrease the incidence of infection, as manifested by febrile neutropenia, in susceptible patients with with non-myeloid cancer receiving myelosuppressive anti-cancer treatment. 8 ...

    DA: 41 PA: 78 MOZ Rank: 33

  • The incidence and clinical features of PEGylated filgrastim …

    nature.com

    https://www.nature.com/articles/s41598-020-75620-6

    WebOct 29, 2020 · 1 Altmetric. Metrics. Abstract. Although PEGylated filgrastim-induced aortitis is very rare and unknown clinically, some cases were reported and increasing, especially in breast cancer...

    DA: 17 PA: 75 MOZ Rank: 15


  • Refining the role of pegfilgrastim (a long-acting G-CSF) for …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610660/

    WebAug 25, 2017 · It was agreed that pegfilgrastim and 11 days’ filgrastim have similar efficacy and safety and that pegfilgrastim is preferred to < 11 days’ filgrastim (and may be preferred to ≥ 11 days’ filgrastim based on adherence and convenience); pegfilgrastim is not appropriate in weekly chemotherapy; in split-dose chemotherapy, pegfilgrastim is …

    DA: 47 PA: 5 MOZ Rank: 59

  • Design Rationale and Development Approach for Pegfilgrastim as …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488452/

    WebMay 22, 2015 · Evaluation of multiple PEGylated forms of filgrastim identified pegfilgrastim, a 20 kDa polyethylene glycol (PEG) fusion protein, as the construct with the optimal balance of in vitro activity and in vivo residence time.

    DA: 50 PA: 53 MOZ Rank: 95

  • Pegylated Filgrastim Versus Filgrastim for Stem Cell ... - PubMed

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/29398647/

    WebChemo-mobilization of peripheral blood CD34 + stem cells (PBSCs) with pegylated filgrastim (pegfilgrastim), a sustained-duration formulation of filgrastim, has been used as an alternative to filgrastim in several studies involving heterogeneous cohorts of lymphoma and multiple myeloma (MM) patients and shown to be equivalent in PBSC yield and ...

    DA: 9 PA: 24 MOZ Rank: 77

  • Pegfilgrastim (Subcutaneous Route) Side Effects - Mayo Clinic

    mayoclinic.org

    https://www.mayoclinic.org/drugs-supplements/pegfilgrastim-subcutaneous-route/side-effects/drg-20066866

    WebPegfilgrastim (Subcutaneous Route) Side Effects. Drug information provided by: Merative, Micromedex ®. Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

    DA: 85 PA: 90 MOZ Rank: 81

  • Filgrastim Injection: MedlinePlus Drug Information

    medlineplus.gov

    https://medlineplus.gov/druginfo/meds/a692033.html

    WebFilgrastim injection products (Granix, Neupogen, Nivestym, Releuko, Zarxio) are used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection).

    DA: 15 PA: 83 MOZ Rank: 73